Leveraged Buyouts
Valeant Acquires Actavis
Valeant Pharmaceuticals is in discussion to acquire Actavis for about US$13 billion. Valeant Pharmaceuticals International Inc, the largest publicly listed drug maker in Canada, is in discussion to purchase generics pharmaceutical firm Actavis Inc for US$13 billion.
Vodafone Shareholders Want Higher Bid
Vodafone shareholders, should the US$100 million bid be offered, wants to either merge with Verizon Communications.
Deadline for EDAC Offer Extended
Greenbriar Equity provides deadlines for shares of stock purchase bids. Greenbriar Equity Group disclosed through an announcement released today that the subsidiary corporation of GB Aero Engine LLC and a partner of Briar, GB Aero Engine Merger will give interested acquirers of EDAC Technology's outstanding shares of common stock until 5:00pm EDT of May 6, 2013 to finalize their offers.
Empire State REIT Faces Uphill Legal Climb
A judge of the New York State Supreme Court is set to decide on whether the buyout provision for opposing investors is legal in the Empire State REIT case.